The analgesic medicine sales in Germany have fluctuated over the past decade, with a notable dip in 2015 and a significant recovery starting from 2021. As of 2023, the market value stood at 2.8 billion USD. Over the last two years, the market has shown consistent growth, with year-on-year variation at 2.49% in both 2022 and 2023. The five-year CAGR from 2018 to 2023 was a healthy 5.44%, indicating strong recovery and market stabilization.
Looking ahead, the future projections up to 2028 suggest a moderate but steady growth trend, with a forecasted five-year CAGR of 1.77% and an overall forecasted growth rate of 9.16% from 2023 to 2028.
Future trends to watch for:
- Increased focus on innovative pain management solutions
- Potential impact of regulatory changes on the market
- Growing consumer preference for non-prescription analgesics
